A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma.
Myung Sun KimTitas BanerjeeAndy ChenAlexey DanilovRenee MacKinnonBria ThurlowSujata ThakurtaKirsten OrandCatherine DegninByung ParkStephen E SpurgeonPublished in: Leukemia & lymphoma (2022)